- Recent Funding
- Investors
- Proxima Ventures Ltd
Proxima Ventures Ltd portfolio
Proxima Ventures Ltd has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Immune-Onc Therapeutics's $131M Series B+ round in January 2023, alongside BOCOM International, TriWise Capital and Qianzhan Investment Management. That company is in Health and bio.
What Proxima Ventures Ltd invests in
- Health and bio · 1 · 100%
- Education · 1 · 100%
How Proxima Ventures Ltd invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $131M |
Proxima Ventures Ltd portfolio companies
IImmune-Onc Therapeutics$131MSeries B+ · Jan 2023
| Company | Round with Proxima Ventures Ltd | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $131M | $211M | Jan 5, 2023 Series B+ |
Most frequent co-investors
BBOCOM International1 shared round · last Jan 5, 2023
TTriWise Capital1 shared round · last Jan 5, 2023
- QQianzhan Investment Management1 shared round · last Jan 5, 2023
Similar investors
CChile Ventures1 company · 1 deal in 12 mo
LLumina Impact Ventures1 companyOOceanpine Capital1 company
RRET Ventures1 company
UUntitled Investments1 company
SSondo Capital2 companies · 2 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Proxima Ventures Ltd. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Proxima Ventures Ltd, which is a subset of its real portfolio. API: /api/v1/investors/proxima-ventures-ltd (get a free API key). More: the most active VC firms and new venture capital funds.